In a preclinical breast cancer model, previously shown to induce neutrophilia [14], we detected an expansion of neutrophils with a reduction in L-selectin (CD62Llow) a change that was previously reported in circulating neutrophils of Triple Negative (TN) breast cancer patients [22]. This evidence concerns the gene SELL and breast carcinoma.